Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2019/03/018303
CTRI/2019/03/018303
Not yet recruiting
Phase 2

Assessment of seminal plasma myeloperoxidase level (ROS)and the effect of vitamin C therapy on semen quality in infertile men - ROS

Dr V Radha0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr V Radha
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Dr V Radha

Eligibility Criteria

Inclusion Criteria

  • •1\. Age 20\-45 years with infertility
  • •2\. Patients with bilateral testies

Exclusion Criteria

  • •1\. Patients on medications for infertility
  • •2\. Patients with known history of diabetes mellitus, hypertension, obesity, infection followed by infection, ischemic heart disease, metabolic syndrome and other chronic illness.
  • •3\. Patients with history of alcohol \> then 60 units/week and smoking
  • •4\. Patients who are allergic to Vitamin C, orchitis TB and varicocele
  • •5\. Patient not willing to participate in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Terminated
Not Applicable
Assessing oxidative stress caused by a meal in healthy malesOxidative stressMetabolic and Endocrine - Metabolic disordersDiet and Nutrition - Other diet and nutrition disorders
ACTRN12619000929101Monash University12
Not yet recruiting
Phase 1
Estimation of protein levels in the saliva before and after scaling and root planing procedure
CTRI/2020/04/024689Rinu Reju
Completed
Not Applicable
Estimation of the activity of marker enzymes ( Paraoxonase 1,Myeloperoxidase) in serum and their relationship with Atherogenic Index of Plasma in patients with abnormal lipid levelsHealth Condition 1: I709- Other and unspecified atherosclerosis
CTRI/2019/01/017177Tejal Deepak Durgekar143
Not yet recruiting
Not Applicable
The influence of myeloperoxidase-deficiency on the vasculatureMyeloperoxidase deficiency, parodontits, chronic inflammationEndothelial Dysfunction
DRKS00019108Medizinische Klinik III, Herzzentrum der Universität zu Köln200
Recruiting
Not Applicable
Study of the neutrophil myelo- peroxidase index (MPXI) with blood disorders, immune disorders or circulatory diseases
JPRN-UMIN000004038Kobe University Graduate School of Health Sciences300